Product Catalogue 2015 Clinical and Industrial Microbiology

Size: px
Start display at page:

Download "Product Catalogue 2015 Clinical and Industrial Microbiology"

Transcription

1

2 Product Catalogue 201 Antibiotic discs in cartridge µg CLSI 1,2 EUCAST 3,4 BSAC Packaging * Amikacin AK x0 Discs 9004 Amoxicillin AML 2 x0 Discs 911 Amoxicillin AML x0 Discs 9133 Amoxicillin AML 2 x0 Discs 9179 Amoxicillin AML x0 Discs 900 Amoxicillin + Clavulanic acid AUG 3 (2+1) x0 Discs 9191 Amoxicillin + Clavulanic acid AUG (20+) x0 Discs 9048 Ampicillin AMP 2 x0 Discs 911 Ampicillin AMP x0 Discs 9006 Ampicillin + Sulbactam AMS 20 (+) x0 Discs 9031 Ampliclox (AMP + CX) ACL (2+) x0 Discs 9122 Azithromycin AZM 1 x0 Discs 9 Azlocillin AZL 7 x0 Discs 9007 Aztreonam ATM x0 Discs 9008 Bacitracin BA IU x0 Discs 901 Carbenicillin CAR 0 x0 Discs 9009 Cefaclor CEC x0 Discs 90 Cefadroxil CDX x00 Discs 902 Cefamandole MA x0 Discs 9014 Cefazolin KZ x0 Discs 901 Cefepime FEP x0 Discs 94 Cefepime + Clavulanic acid FEL 40 (+) 6 x0 Discs 9143 Cefixime CFM x0 Discs 9089 Cefoperazone CFP x0 Discs 9016 Cefoperazone CFP 7 x0 Discs 98 Cefotaxime CTX x0 Discs 912 Cefotaxime CTX 6 x0 Discs 9017 Cefotaxime + Clavulanic acid CTL 40 (+) 6 x0 Discs 9182 Cefotaxime + Clavulanic acid + Cloxacillin CTLC 6 x0 Discs 9203 Cefotetan CTT x0 Discs 9081 Cefoxitin FOX x0 Discs 9018 Cefoxitin + Cloxacillin FOC 2 (+200) 0) x0 Discs 9144 Cefpirome CR x0 Discs 918 Cefpodoxime PX x0 Discs 9064 Cefpodoxime + Clavulanic acid PXL 11 (+1) 6 x0 Discs 9190 Cefprozil CPR x0 Discs 9112 Cefsulodin CSD x0 Discs 903 Ceftaroline CPT x0 Discs 919 Ceftaroline CPT x0 Discs 9198 Ceftazidime CAZ x0 Discs 913 Ceftazidimee CAZ x0 Discs 9019 Ceftazidime e + Clavulanic acid CAL 40 (+) 6 x0 Discs 914 Ceftazidime + Clavulanic acid + Cloxacillin CALC 6 x0 Discs 9204 Ceftibuten CTB x0 Discs 91 Ceftizoxime CZX x0 Discs 904 Ceftriaxone CRO x0 Discs 9020 Cefuroxime CXM x0 Discs 9021 Cephalexin CL x0 Discs 9011 Cephalothin KF x0 Discs 9013 Cephradine CE x0 Discs 90 Chloramphenicol C x0 Discs 9128 Chloramphenicol C x0 Discs 9022 Cinoxacin CIN 0 x0 Discs 907 Ciprofloxacin CIP x0 Discs 906 Clarithromycin CLR 1 x0 Discs 9098 Clindamycin CD 2 x0 Discs 9047 Clindamycin CD x0 Discs 9146 Cloxacillin CX x0 Discs 908 MICROPLA ET 20

3 Product Catalogue 201 Antibiotic discs in cartridge µg CLSI 1,2 EUCAST 3,4 BSAC Packaging * Colistin sulfate CS x0 Discs 9023 Colistin sulfate CS 2 x0 Discs 9184 Colistin sulfate CS IU x0 Discs 9141 Daptomycin (Includes Ca 2+ ) DAP x0 Discs 9090 Dicloxacillin DCX 1 x0 Discs 9093 Dipicolinic acid DP x0 Discs 9194 Doripenem DOR x0 Discs 914 Doxycycline DXT x0 Discs 909 EDTA ED x0 Discs 9087 Ertapenem ETP x0 Discs 9061 Ertapenem + Cloxacillin ET+CL x0 Discs 9199 Ertapenem + Phenylboronic acid ET+BO x0 Discs 9202 Erythromycin E 2 x0 Discs 9180 Erythromycin E 1 x0 Discs 9024 Fosfomycin FOS 0 x0 Discs 902 Fosfomycin (includes G-6-P) FOS 0 x0 Discs 9121 Fosfomycin (includes G-6-P) FOS 200 x0 Discs 99 Furazolidon FR 0 x00 Discs 9099 Fusidic acid FC x0 Discs 9049 Fusidic acid FC x0 Discs 9111 Gatifloxacin GAT x0 Discs 9169 Gentamicin CN x0 Discs 9026 Gentamicin CN x0 Discs 912 Gentamicin CN 120 x0 Discs 9124 Imipenem IMI x0 Discs 9079 Imipenem + Phenylboronic acid IMI+BO x0 Discs 908 Imipenem + Cloxacillin IMI+CL x0 Discs 9086 Imipenem + EDTA IMD 760 (+70) x0 Discs 9183 Kanamycin K x0 Discs 9027 Levofloxacin x0 Discs 92 Lincomycin MY 2 x0 Discs 9028 Lincomycin MY 1 x0 Discs 9116 Linezolid LNZ x0 Discs 91 Linezolid LNZ x0 Discs 9136 Lomefloxacin LOM x0 Discs 9113 Loracarbef LOR x0 Discs 9173 Mecillinam MEC x0 Discs 916 Meropenem MRP x0 Discs 9068 Meropenem + Phenylboronic acid MR+BO 6 x0 Discs 9176 Meropenem + Cloxacillin MR+CL 6 x0 Discs 917 Meropenem + Dipicolinic acid MR+DP 6 x0 Discs 9177 Meropenem + EDTA MR+ED 6 x0 Discs 9178 Methicillin MET x0 Discs 9029 Metronidazole MTZ x0 Discs 9076 Metronidazole MTZ x0 Discs 9188 Metronidazole MTZ 0 x0 Discs 9119 Mezlocillin MEZ 7 x0 Discs 9062 Minocycline MN x0 Discs 90 Miokamicin MK 1 x0 Discs 96 Moxifloxacin MOX x0 Discs 93 Mupirocin MUP x0 Discs 9189 Mupirocin MUP 200 x0 Discs 917 Nafcillin NAF 1 x0 Discs 9174 Nalidixic acid NA x0 Discs 9001 Neomycin N x0 Discs 9032 Netilmicin x0 Discs 9170 Netilmicin x0 Discs 9033 Nitrofurantoin F 0 x0 Discs 9181 Nitrofurantoin F 0 x0 Discs 918 Nitrofurantoin F 0 x0 Discs 9034 MICROPLA PLA ET 21

4 Product Catalogue 201 Antibiotic discs in cartridge µg CLSI 1,2 EUCAST 3,4 BSAC Packaging * Norfloxacin NOR x0 Discs 903 Novobiocin NO x0 Discs 9117 Novobiocin NO x0 Discs 9063 Ofloxacin OFX x0 Discs 9080 Oxacillin OX 1 x0 Discs 9036 Oxacillin OX x0 Discs 913 Oxolinic acid OA 2 x0 Discs 9002 Oxytetracycline OT x0 Discs 906 Pefloxacin PEF x0 Discs 9091 Penicillin G P 1 IU x0 Discs 91 Penicillin G P 2 IU x0 Discs 9127 Penicillin G P IU x0 Discs 9037 Phenoxymethylpenicillin PV x0 Discs 9171 Phenylboronic acid BO x0 Discs 9193 Pipemidic acid PI 20 x0 Discs 9003 Piperacillin PRL x0 Discs 919 Piperacillin PRL 0 x0 Discs 9038 Piperacillin + Tazobactam TZP 36 (+6) x00 Discs 9160 Piperacillin + Tazobactam TZP 1 (0+) x0 Discs 90 Polymyxin B PB 0 IU x0 Discs 9066 Polymyxin B PB 0 IU x0 Discs 9120 Quinupristin-Dalfopristin QDA 1 x0 Discs 9161 Rifampicin RD x0 Discs 9118 Rifampicin RD x0 Discs 9039 Rokitamycin ROK x0 Discs 9192 Roxithromycin RXT 1 x0 Discs 9060 Sisomycin SIS x0 Discs 9046 Sodium Fusidate FC x0 Discs 9131 Spectinomycin SPC 0 x0 Discs 9067 Spiramycin SP 0 x0 Discs 9088 Streptomycin S x0 Discs 9040 Streptomycin S 0 x0 Discs 9162 Sulbactam SU 20 x0 Discs 9129 Sulfadiazine SUZ 0 x0 Discs 910 Sulfafurazole SF 0 x0 Discs 9041 Sulfamethoxazole SMX 0 x0 Discs 9084 Sulfamethoxazole SMX 0 x0 Discs 9187 Sulfaprim SXT 0 x0 Discs 9132 Sulfonamide S3 0 x0 Discs 9126 Teicoplanin TEC x0 Discs 900 Telithromycin TEL 1 x0 Discs 9172 Temocillin TMO 6 x0 Discs 9186 Tetracycline TE x0 Discs 9043 Tiamulin T 7 x0 Discs 9094 Ticarcillin TC 7 x0 Discs 9070 Ticarcillin lin + Clavulanic acid TTC 8 (7+) x0 Discs 9096 Tigecycline TGC 1 x0 Discs 9147 Tobramycin TOB x0 Discs 9044 Tobramycin TOB x0 Discs 9163 Trimethoprim TM 2. x0 Discs 9083 Trimethoprim TM x0 Discs 91 Trimethoprim-Sulfamethoxazole SXT 2 ( ) x0 Discs 9042 Tylosin TY x0 Discs 9082 Vancomycin VA x0 Discs 9164 Vancomycin VA x0 Discs 904 MICROPLA PLA ET * Single cartridges of 0 discs are available: add /1 to the catalogue ref. no. to indicate the relevant item. Example: ref. 904/1 indicates Vancomycin µg in one single cartridge of 0 discs. 22

5 Product Catalogue CLSI. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fourth Informational Supplement. CLSI document M0-S2. Wayne, PA: Clinical and Laboratory Standards Institute; CLSI. Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard - Tenth Edition. CLSI document M02-A12. Wayne, PA: Clinical and Laboratory Standards Institute; The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version.0, Routine and extended internal quality control as recommended by EUCAST, Version.0. BSAC Methods for Antimicrobial Susceptibility Testing, Version 12, May EUCAST guidelines for detection of resistance mechanisms and specific resistances of clinical and/or epidemiological importance. Version 1.0, CLSI. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals; Approved Standard - Third Edition. CLSI document M31-A3. Wayne, PA: Clinical and Laboratory Standards Institute; Antimycotic discs in cartridge µg CLSI Packaging* Amphotericin B AMB 20 x0 Discs 9071 Caspofungin CAS x0 Discs 916 Clotrimazole CLO 0 x0 Discs 9097 Econazole ECN x0 Discs 9072 Fluconazole FLU 2 x0 Discs 9166 Fluconazole FLU 0 x0 Discs 9069 Flucytosine AFY 1 x0 Discs 9073 Griseofulvin AGF x0 Discs 9074 Itraconazole ITC 0 x0 Discs 97 Ketoconazole KCA x0 Discs 907 Miconazole MCL x0 Discs 9077 Nystatin NY 0 IU x0 Discs 9078 Posaconazole POS x0 Discs 9167 Voriconazole VO 1 x0 Discs 9168 * Single cartridges of 0 discs are available: add /1 to the catalogue ref. no. to indicate the relevant item. Example: ref. 907/1 indicates Ketoconazole µg in one single cartridge of 0 discs. NOTE: 8. CLSI M44-A2 4-A2 - Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts; Approved Guideline Second Edition (August 2009). 9. CLSI M44 S3 - Zone Diameter Interpretive Standards, Corresponding Minimal Inhibitory Concentration (MIC) Interpretive Breakpoints, and Quality Control Limits for Antifungal Disk Diffusion Susceptibility Testing of Yeasts;Third Informational Supplement. MICROPLA LA 23

6 Product Catalogue 201 Est Liofilchem s.r.l. ESBL discs kit (according to EU UCAST) Cefotaxime Cefotaxime + Clavulanic acid Ceftazidime Ceftazidime + Clavulanic acid Cefepime Cefepime + Clavulanic acid CTX CTL CAZ CAL FEP FEL µg 40 (+) 40 (+) 40 (+) Packaging 0 Test µg 40 (+) 40 (+) Packaging g ESBL discs kit (according to CLSI) CTX CTL CAZ CAL IC R O PL A N ET Cefotaxime Cefotaxime + Clavulanic acid Ceftazidime Ceftazidime + Clavulanic acid 0 Test Te Packa Packaging 0 Test Packaging 0 Test Packaging 0 Test ESBL (chromosomal ind. AmpC C) discs kit (acc cording to EUCAST) AST) Cefepime Cefepime + Clavulanic acid FEP FEL µg 40 (+) KPC&MBL discs kit (accordingg to EUC CAST) Meropenem Meropenem + Phenylboronic acid Meropenem + Cloxacillin Meropenem + Dipicolinic acid MRP MR+BO MR+CL MR+DP µg KPC&MBL&OXA-48 discs kit MR MRP MR+BO R+CL MR+CL M MR+DP TM TMO µg M Meropenem Meropenem + Phenylboronic acid Meropenem + Cloxacillin c acid Meropenem + Dipicolinic Temocillin 24

7 Product Catalogue 201 AmpC discs kit µg Packaging Cefotaxime Cefotaxime + Cloxacillin Ceftazidime 0 Test Ceftazidime + Cloxacillin ESBL+AmpC screen discs kit µg Packaging Cefotaxime Cefotaxime + Clavulanic acid 40 (+) Cefotaxime + Cloxacillin 0 Test Cefotaxime + Clavulanic acid + Cloxacillin MICROPLA 2

8 Product Catalogue 201 Multodisc with eight antimicrobial agents µg CLSI EUCAST Packaging ANAEROBES Carbenicillin Cefoxitin Clindamycin CAR FOX CD 0 2 Chloramphenicol C Erythromycin E 1 0 Multodiscs 9200 Metronidazole Ampicillin Tetracycline MTZ AMP TE ENTEROCOCCI Tigecycline Ampicillin Linezolid TGC AMP LNZ 1 2 Nitrofurantoin F 0 Trimethoprim-Sulfamethoxazole SXT 2 0 Multodiscs 92 Vancomycin Gentamicin Teicoplanin VA CN TEC ENTEROBACTERIA URINE Levofloxacin Ampicillin Cefuroxime AMP CXM Ceftazidime CAZ Trimethoprim-Sulfamethoxazolem-Sulfamethoxazole SXT 2 0 Multodiscs 92 Gentamicin n Nitrofurantoin toin Norfloxacin CN F NOR 0 ENTEROBACTERIA 1 Amikacin Aztreonam AK ATM Piperacillin + Tazobactam TZP 36 Chloramphenicol C Trimethoprim-Sulfamethoxazole SXT 2 0 Multodiscs 9220 Netilmicin Cefotaxime Nitrofurantoin CTX F 0 ENTEROBACTERIA EROBACTERIA 2 Levofloxacin Cefoxitin FOX Piperacillin + Tazobactam TZP 36 Cefuroxime CXM Streptomycin S 0 0 Multodiscs 9240 Netilmicin Ampicillin + Sulbactam Tobramycin AMS TOB 20 PSEUDOMONAS MICROPLA MICROPLANEckaging Amikacin Ticarcillin Piperacillin + Tazobactam Ceftazidime Gentamicin Netilmicin Levofloxacin Tobramycin AK TC TZP CAZ CN TOB Multodiscs

9 Product Catalogue 201 Multodisc with eight antimicrobial agents µg CLSI EUCAST Packaging STAPH STREPTO ACIOBACTER YEASTS Cefoxitin Levofloxacin Netilmicin Tetracycline Erythromycin Gentamicin Rifampicin Linezolid Penicillin G Levofloxacin Teicoplanin Vancomycin Erythromycin Tetracycline Linezolid Rifampicin Doripenem Meropenem Levofloxacin Gentamicin Trimethoprim-Sulfamethoxazolem-Sulfamethoxazole Tobramycin Ciprofloxacin Netilmicin Caspofungin Fluconazole Posaconazole Voriconazole Amphotericin B Ketoconazole Flucytosine Nystatin FOX TE ERY CN RD LNZ P TEC VA E TE LNZ RD DOR MRP CN SXT TOB CIP CAS FLU POS VO AMB KCA AFY NY 1 IU IU 0 Multodiscs Multodiscs Multodiscs Multodiscs 9280 MICROPLA MICROPLANEckaging 27

10 Product Catalogue 201 Disc Dispenser Disc Dispenser for 1 cartridge Disc Dispenser for 6 cartridges Disc Dispenser for 8 cartridges Disc Dispenser for 12 cartridges Automatic handsfree rotation plater Automatic Handsfree Rotation Plater rpm includes adaptor for 90 mm petri dishes Automatic Handsfree Rotation Plater PRO rpm includes adaptor for 90 mm petri dishes Turntable extra wide adaptor for 140 mm petri dishes Wireless Foot Pedal Steel Foot Pedal Plastic Foot Pedal Densitometer MIC ICR CROPLA ET DEN-1B McFarland densitometer with built-in adapter for 18 mm tubes A Adapter for 16 mm tubes CKG18, calibration kit for DEN-1, for 18mm glass tubes CKG16, calibration kit for DEN-1, for 16mm glass tubes

Liofilchem - Antibiotic Disk Interpretative Criteria and Quality Control - F14013 - Rev.7 / 20.02.2013

Liofilchem - Antibiotic Disk Interpretative Criteria and Quality Control - F14013 - Rev.7 / 20.02.2013 Liofilchem Antibiotic Disk Interpretative Criteria and Quality Control F0 Rev.7 /.02. Amikacin AK Amoxicillin + Clavulanic acid AUG (+) ATCC 352 Coagulasenegative staphylococci Amoxicillin + Clavulanic

More information

Date: November 30, 2010

Date: November 30, 2010 Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Date: November 30, 2010 To: Through: From: Subject: Drug Name(s): Application

More information

Drug Use Review. Edward Cox, M.D. Director Office of Antimicrobial Products

Drug Use Review. Edward Cox, M.D. Director Office of Antimicrobial Products Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Drug Use Review Date: April 5, 2012 To: Through: Edward Cox, M.D. Director

More information

ANTIMICROBIAL AGENT CLASSES AND SUBCLASSES

ANTIMICROBIAL AGENT CLASSES AND SUBCLASSES ANTIMICROBIAL AGENT CLASSES AND SUBCLASSES FOR USE WITH CLSI DOCUMENTS M2 AND M7 Beta-lactams: penicillins e penicillin a penicillin beta-lactam/beta-lactamase inhibitor combinations aminopenicillin a

More information

Determination of minimum inhibitory concentrations. Jennifer M. Andrews* Department of Microbiology, City Hospital NHS Trust, Birmingham B18 7QH, UK

Determination of minimum inhibitory concentrations. Jennifer M. Andrews* Department of Microbiology, City Hospital NHS Trust, Birmingham B18 7QH, UK Journal of Antimicrobial Chemotherapy (2001) 48, Suppl. S1, 5 16 Determination of minimum inhibitory concentrations JAC Jennifer M. Andrews* Department of Microbiology, City Hospital NHS Trust, Birmingham

More information

British Society for Antimicrobial Chemotherapy

British Society for Antimicrobial Chemotherapy British Society for Antimicrobial Chemotherapy BSAC to actively support the EUCAST Disc Diffusion Method for Antimicrobial Susceptibility Testing in preference to the current BSAC Disc Diffusion Method

More information

The 14th EURL-AR Proficiency Test - enterococci, staphylococci and E. coli 2013. Lina Cavaco Susanne Karlsmose Rene S. Hendriksen Frank M.

The 14th EURL-AR Proficiency Test - enterococci, staphylococci and E. coli 2013. Lina Cavaco Susanne Karlsmose Rene S. Hendriksen Frank M. The 14th EURL-AR Proficiency Test - enterococci, staphylococci and E. coli 2013 Lina Cavaco Susanne Karlsmose Rene S. Hendriksen Frank M. Aarestrup The 14TH EURL-AR Proficiency Test Enterococci, Staphylococci

More information

Dosing information in renal impairment

Dosing information in renal impairment No. Drug name Usual dose Adjustment for Renal failure estimated CrCl (ml/min) Aminoglycoside antibiotics 1 Amikacin 2 Gentamicin 7.5 mg /kg q 12 hr > 50-90 7.5 mg/kg q 12 hr 10-50 7.5 mg/kg q 24 hr < 10

More information

HUSRES Annual Report 2008 Martti Vaara. www.huslab.fi www.intra.hus.fi

HUSRES Annual Report 2008 Martti Vaara. www.huslab.fi www.intra.hus.fi HUSRES Annual Report 2008 Martti Vaara www.huslab.fi www.intra.hus.fi The basis of this HUSRES 2008 report is the HUSLAB/Whonet database 2008, which contains susceptibility data on about 180.000 bacteria

More information

HUSRES Annual Report 2010 Martti Vaara www.huslab.fi www.intra.hus.fi

HUSRES Annual Report 2010 Martti Vaara www.huslab.fi www.intra.hus.fi HUSRES Annual Report 2010 Martti Vaara www.huslab.fi www.intra.hus.fi Martti Vaara, 2/2011 1 The basis of this HUSRES 2010 report is the HUSLAB/Whonet database 2010, which contains susceptibility data

More information

for Extended Stability Parenteral Drugs Third Edition Caryn M. Bing, R.Ph., M.S., FASHP Editor

for Extended Stability Parenteral Drugs Third Edition Caryn M. Bing, R.Ph., M.S., FASHP Editor Extended Stability for Parenteral Drugs Third Edition Editor Caryn M. Bing, R.Ph., M.S., FASHP 1 American Society of Health-System Pharmacists Bethesda, Maryland Contents Preface Acknowledgments x/ Dedication

More information

How To Treat Mrsa From A Dead Body

How To Treat Mrsa From A Dead Body HUSRES Annual Report 2012 Martti Vaara www.huslab.fi www.intra.hus.fi Martti Vaara 2013 1 The basis of this HUSRES 2012 report is the HUSLAB/Whonet database 2012, which contains susceptibility data on

More information

Urinary Tract Infections

Urinary Tract Infections Urinary Tract Infections Overview A urine culture must ALWAYS be interpreted in the context of the urinalysis and patient symptoms. If a patient has no signs of infection on urinalysis, no symptoms of

More information

How To Treat Mrsa In Finnish

How To Treat Mrsa In Finnish HUSRES Annual Report 2013 Martti Vaara www.huslab.fi www.intra.hus.fi Martti Vaara 2014 1 The basis of this HUSRES 2013 report is the HUSLAB/Whonet database 2013, which contains susceptibility data on

More information

HUSRES Annual Report 2015

HUSRES Annual Report 2015 HUSRES Annual Report 2015 1 This report is based on the HUSLAB/Whonet database 2015, which contains data on more than 190.000 microbes. EUCAST 2015 clinical breakpoints have mainly been used. The doses

More information

Received 4 July 2010; returned 10 August 2010; revised 27 September 2010; accepted 30 September 2010

Received 4 July 2010; returned 10 August 2010; revised 27 September 2010; accepted 30 September 2010 J Antimicrob Chemother 2011; 66: 205 209 doi:10.1093/jac/dkq404 Advance Access publication 8 November 2010 Sustained reduction in antimicrobial use and decrease in methicillin-resistant Staphylococcus

More information

Version 11.1 May 2012

Version 11.1 May 2012 BSAC Methods for Antimicrobial Susceptibility Testing Version 11.1 May 2012 All enquiries to: Jenny Andrews at: + 44 (0) 121 507 5693 Email: [email protected] Contents Page Working Party members 5

More information

BD Sensi-Disc Susceptibility Test Discs

BD Sensi-Disc Susceptibility Test Discs INSTRUCTIONS FOR USE BD SENSI-DISCS SD-BD.01 Rev.: May 2005 BD Sensi-Disc Susceptibility Test Discs INTENDED USE Sensi-Disc susceptibility test discs are used for semi-quantitative in vitro susceptibility

More information

OXOiD KÜLTÜR BESİYERLERİ

OXOiD KÜLTÜR BESİYERLERİ AG 020 C OXOID PLASTIC POUCHES for ANAEROGEN & CAMPYGEN 1 x 20 Adet AG 025 A OXOID ANAEROJAR 2.5lt. 1 Adet AG 029 A OXOID ANAEROJAR PLATE CARRIER 1 Adet AN 005 C OXOID SEALING CLIPS for PLASTIC POUCHES

More information

Appropriate Treatment for Children with Upper Respiratory Infection

Appropriate Treatment for Children with Upper Respiratory Infection BCBS ACO Measure Appropriate Treatment for Children with Upper Respiratory Infection HEDIS Measure CPT II coding required: YES Click here to go to Table of Contents BCBS Measure: Page 50 of 234 Dated:

More information

Antibiotikaanvändning

Antibiotikaanvändning Antibiotikaanvändning Akademiska sjukhuset T o m juni 2014 Receptförskriven och rekvirerad antibiotika (J01 inkl rifampicin)* Akademiska sjukhuset 2008 - juni 2014 Källa: ehälsomyndigheten 350 000 300

More information

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY Measure #65 (NQF 0069): Appropriate Treatment for Children with Upper Respiratory Infection (URI) National Quality Strategy Domain: Efficiency and Cost Reduction 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES:

More information

Helsingin ja Uudenmaan alueen herkkyystilastoja 2004. www.huslab.fi www.intra.hus.fi

Helsingin ja Uudenmaan alueen herkkyystilastoja 2004. www.huslab.fi www.intra.hus.fi Helsingin ja Uudenmaan alueen herkkyystilastoja 2004 www.huslab.fi www.intra.hus.fi Staph. aureus 2004 (%R+I) Pus and blood isolates at six hospitals (M,T,L,K,N,Ma) in Helsinki University Central Hospital,

More information

Version 12 May 2013. BSAC Methods for Antimicrobial Susceptibility Testing. All enquiries to: Mandy Wootton. Email: [email protected].

Version 12 May 2013. BSAC Methods for Antimicrobial Susceptibility Testing. All enquiries to: Mandy Wootton. Email: Mandy.Wootton@wales.nhs. BSAC Methods for Antimicrobial Susceptibility Testing Version 12 May 2013 All enquiries to: Mandy Wootton Email: [email protected] Telephone: +44 (0) 2920 746581 Contents Page Working Party members

More information

SEA-HLM-415 Distribution: General. Establishment of national laboratory-based surveillance of antimicrobial resistance

SEA-HLM-415 Distribution: General. Establishment of national laboratory-based surveillance of antimicrobial resistance SEA-HLM-415 Distribution: General Establishment of national laboratory-based surveillance of antimicrobial resistance World Health Organization 2011 All rights reserved. Requests for publications, or for

More information

The 11 th EURL-AR Proficiency Testing Salmonella and Campylobacter 2011. Susanne Karlsmose Lina M. Cavaco Rene S. Hendriksen Frank M.

The 11 th EURL-AR Proficiency Testing Salmonella and Campylobacter 2011. Susanne Karlsmose Lina M. Cavaco Rene S. Hendriksen Frank M. The 11 th EURL-AR Proficiency Testing Salmonella and Campylobacter 2011 Susanne Karlsmose Lina M. Cavaco Rene S. Hendriksen Frank M. Aarestrup European Union Reference Laboratory - Antimicrobial Resistance

More information

FORMULARY. (List of Covered Drugs) Molina Dual Options Medicare-Medicaid Plan

FORMULARY. (List of Covered Drugs) Molina Dual Options Medicare-Medicaid Plan FORMULARY (List of Covered Drugs) 2015 Molina Dual Options Medicare-Medicaid Plan Version 14 UPDATED: 11/2015 Member Services (877) 901-8181, TTY/TDD 711 Monday - Friday, 8 a.m. - 8 p.m. local time H8046_15_16003_0002_MMPILRx

More information

CODE NO. PRODUCT NAME METHODOLOGY PACK SIZE HEPATITIS C

CODE NO. PRODUCT NAME METHODOLOGY PACK SIZE HEPATITIS C CODE NO. PRODUCT NAME METHODOLOGY PACK SIZE HEPATITIS C 53FT200-10 Signal HCV Ver. 2.0 Flow Through 10 Tests 53FT200-50 Signal HCV Ver. 2.0 Flow Through 50 Tests 53EL100-96 Innova ELISA 96 Wells HEPATITIS

More information

Disc Diffusion Susceptibility Methods

Disc Diffusion Susceptibility Methods Disc Diffusion Susceptibility Methods Introduction When a filter paper disc impregnated with a chemical is placed on agar the chemical will diffuse from the disc into the agar. This diffusion will place

More information

Practice Guidelines. Updated Guideline on Diagnosis and Treatment of Intra-abdominal Infections

Practice Guidelines. Updated Guideline on Diagnosis and Treatment of Intra-abdominal Infections Updated Guideline on Diagnosis and Treatment of Intra-abdominal Infections CARRIE ARMSTRONG Guideline source: Surgical Infection Society, Infectious Diseases Society of America Literature search described?

More information

Oscar E. Guzman, PharmD, BCPS

Oscar E. Guzman, PharmD, BCPS P Chapter 32 Antibiotic Streamlining Oscar E. Guzman, PharmD, BCPS Introduction Antibiotic streamlining is one of the most important methods pharmacists can use to encourage appropriate antibiotic use,

More information

Received 22 March 2006/Returned for modification 2 May 2006/Accepted 14 September 2006

Received 22 March 2006/Returned for modification 2 May 2006/Accepted 14 September 2006 JOURNAL OF CLINICAL MICROBIOLOGY, Nov. 2006, p. 4085 4094 Vol. 44, No. 11 0095-1137/06/$08.00 0 doi:10.1128/jcm.00614-06 Copyright 2006, American Society for Microbiology. All Rights Reserved. Two-Center

More information

Welcome. Quality. Ethical Statement. Website This Catalogue is available electronically from our website: www.mastgrp.com

Welcome. Quality. Ethical Statement. Website This Catalogue is available electronically from our website: www.mastgrp.com IVD solutions through partnership Welcome Welcome to the Mast Group Ltd. Product Catalogue effective from January 1st, 2015. The catalogue comprises ordering information on Mast s extensive portfolio of

More information

AETNA BETTER HEALTH OF OHIO a MyCare Ohio plan

AETNA BETTER HEALTH OF OHIO a MyCare Ohio plan AETNA BETTER HEALTH OF OHIO a MyCare Ohio plan 2015 List of Covered Drugs/Formulary Aetna Better Health of Ohio, a MyCare Ohio plan (Medicare-Medicaid Plan) is a health plan that contracts with Medicare

More information

ORIGINAL ARTICLE. 10.1111/j.1469-0691.2006.01613.x

ORIGINAL ARTICLE. 10.1111/j.1469-0691.2006.01613.x ORIGINAL ARTICLE 10.1111/j.1469-0691.2006.01613.x Benchmarking antimicrobial drug use at university hospitals in five European countries V. Vlahović-Palc evski 1, U. Dumpis 2, P. Mitt 3, J. Gulbinovic

More information

ANNUAL REPORT ON STAPHYLOCOCCUS AUREUS BACTERAEMIA CASES IN DENMARK 2008 (part I)

ANNUAL REPORT ON STAPHYLOCOCCUS AUREUS BACTERAEMIA CASES IN DENMARK 2008 (part I) ANNUAL REPORT ON STAPHYLOCOCCUS AUREUS BACTERAEMIA CASES IN DENMARK 2008 (part I) STAPHYLOCOCCUS LABORATORY, STATENS SERUM INSTITUT 1 Staphylococcus aureus bacteraemia annual report, part I The format

More information

CMT - Copan Milk Test

CMT - Copan Milk Test - Copan Milk Test for the detection of Antibiotics & Sulphonamides in milk and milk products - Copan Milk Test Copan Milk Test () Description and principle of the test is available as a single test which

More information

ANNUAL REPORT ON STAPHYLOCOCCUS AUREUS BACTERAEMIA CASES IN DENMARK 2009 (part I)

ANNUAL REPORT ON STAPHYLOCOCCUS AUREUS BACTERAEMIA CASES IN DENMARK 2009 (part I) ANNUAL REPORT ON STAPHYLOCOCCUS AUREUS BACTERAEMIA CASES IN DENMARK 2009 (part I) STAPHYLOCOCCUS LABORATORY, STATENS SERUM INSTITUT 1 Staphylococcus aureus Bacteraemia Annual Report, Part I The annual

More information

Antimicrobial Therapy. Otolaryngology Head and Neck Surgery

Antimicrobial Therapy. Otolaryngology Head and Neck Surgery Pocket Guide to Antimicrobial Therapy in Otolaryngology Head and Neck Surgery 13th Edition DAVID N.F. FAIRBANKS, M.D. The American Academy of Otolaryngology Head and Neck Surgery Foundation EMPIRIC DRUG

More information

NEW SCHEDULE H1 INSERTED IN DRUGS AND COSMETICS RULES :

NEW SCHEDULE H1 INSERTED IN DRUGS AND COSMETICS RULES : LOCOST 85, GIDC Estate, Por-Ramangamdi, N.H.8, Dist. Vadodara - 391 243 Gujarat, India. Tel. No.: (91-265) 2830009 Fax No.: (P.P.) 2831446 E-mail: [email protected] Website: www.locostindia.com A Public

More information

A Determination of Veterinary Drug Residues in Milk Using Polymeric SPE and UHPLC-MS/MS Analysis

A Determination of Veterinary Drug Residues in Milk Using Polymeric SPE and UHPLC-MS/MS Analysis A Determination of Veterinary Drug Residues in Milk Using Polymeric SPE and UHPLC-MS/MS Analysis UCT Part Numbers: ECHLD126-P EnviroClean HLDVB, 200 mg/6ml SPE cartridge, PE Frit SLDA100ID21-18UM Selectra

More information

Vancomycin. Beta-lactams. Beta-lactams. Vancomycin (Glycopeptide) Rifamycins (rifampin) MID 4

Vancomycin. Beta-lactams. Beta-lactams. Vancomycin (Glycopeptide) Rifamycins (rifampin) MID 4 Antibiotic Classes Introduction to Antimicrobials Rachel J. Gordon, MD, MPH Assistant Professor of Clinical Medicine and Epidemiology Beta-lactams Inhibit cell wall synthesis Penicillins Cephalosporins

More information

OXOID FİYAT LİSTESİ ÜRÜN AÇIKLAMASI

OXOID FİYAT LİSTESİ ÜRÜN AÇIKLAMASI ANTİBİYOGRAM DİSKLERİ 1 CT 107 B OXOID AMIKACIN 30 μg AK 5x50 Disk 2 CT 061 B OXOID AMOXYCILLIN 25 μg AML 5x50 Disk 3 CT 060 B OXOID AMOXYCILLIN 2 μg AML 5x50 Disk 4 CT 161 B OXOID AMOXYCILLIN 10 μg AML

More information

Optimizing Antimicrobial Susceptibility Test Reporting

Optimizing Antimicrobial Susceptibility Test Reporting JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 2011, p. S15 S19 0095-1137/11/$12.00 doi:10.1128/jcm.00712-11 Copyright 2011, American Society for Microbiology. All Rights Reserved. VOL. 49, NO. 9 SUPPL. Optimizing

More information

Penetration of Antimicrobial Agents into the Prostate

Penetration of Antimicrobial Agents into the Prostate Pharmacology Chemotherapy 2003;49:269 279 DOI: 10.1159/000074526 Received: December 23, 2002 Accepted after revision: March 18, 2003 Penetration of Antimicrobial Agents into the Prostate Konstantin Charalabopoulos

More information

INTRAVENOUS DRUG QUICKGUIDE

INTRAVENOUS DRUG QUICKGUIDE INTRAVENOUS DRUG QUICKGUIDE GENERAL NOTES IMPORTANT THIS GUIDE IS AN AIDE MEMOIRE ONLY, AND SHOULD NOT REPLACE YOUR PROFESSIONAL REQUIREMENT TO USE MANUFACTUER S LICENSED INFORMATION TO INFORM YOUR PREPARATION

More information

Streptococcus pneumoniae IgG AB (13 Serotypes), MAID... 7

Streptococcus pneumoniae IgG AB (13 Serotypes), MAID... 7 Volume 12 December 2011 Table of Contents Summary of Test Changes... 3 Test Changes... 6 Human Anti-Mouse AB (HAMA), ELISA... 6 Hepatitis E Antibody (IgG, IgM)... 6 Hepatitis E Antibody (IgG)... 6 Hepatitis

More information

Treatment of Fever and Infection in Children with Transfusion Dependent Thalassaemia

Treatment of Fever and Infection in Children with Transfusion Dependent Thalassaemia Treatment of Fever and Infection in Children with Transfusion Dependent Thalassaemia Document Information Version: 2 Date: June 2014 Authors (incl. job title): Professor David Rees, Sue Height (consultant

More information

GLOBAL OVERVIEW OF ANTIMICROBIAL RESISTANCE STD AGENTS

GLOBAL OVERVIEW OF ANTIMICROBIAL RESISTANCE STD AGENTS GLOBAL OVERVIEW OF ANTIMICROBIAL RESISTANCE STD AGENTS IN Dr.P.Bhalla Director Professor and Head Dept. of Microbiology Maulana Azad Medical College New Delhi, INDIA STDs & RTIs l HIV l Gonococcal infections/

More information

Appendix M: Guidelines for the Prophylaxis and Management of Intraabdominal, Biliary, and Appendiceal Infections

Appendix M: Guidelines for the Prophylaxis and Management of Intraabdominal, Biliary, and Appendiceal Infections Appendix M: Guidelines for the Prophylaxis and Management of Intraabdominal, Biliary, and Appendiceal Infections University of Wisconsin Hospital and Clinics Intraabdominal Infections Prophylaxis and Management

More information

bactericidal Gram+ streptococci, enterococci, meningococci, treponema pallidum (syphilis), most anaerobes poor activity against Gram- rods

bactericidal Gram+ streptococci, enterococci, meningococci, treponema pallidum (syphilis), most anaerobes poor activity against Gram- rods Penicillin binds penicillin binding beta-lactamase proteins (transpeptidases, cleaves beta-lactam carboxypeptidases); ring and inactivates enzymes involved in cell drug wall (peptidoglycan) (chromosomal

More information

SHEA Position Paper. Vol. 18 No. 4 INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY 275

SHEA Position Paper. Vol. 18 No. 4 INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY 275 Vol. 18 No. 4 INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY 275 SHEA Position Paper Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention

More information

OIE LIST OF ANTIMICROBIAL AGENTS OF VETERINARY IMPORTANCE

OIE LIST OF ANTIMICROBIAL AGENTS OF VETERINARY IMPORTANCE Criteria used for categorisation List of antimicrobial agents OIE LIST OF OF VETERINARY IMPORTANCE The OIE 1 International Committee unanimously adopted the List of Antimicrobial Agents of Veterinary Importance

More information

NewYork-Presbyterian Hospital Sites: Columbia University Medical Center Guideline: Medication Use Manual Page 1 of 12

NewYork-Presbyterian Hospital Sites: Columbia University Medical Center Guideline: Medication Use Manual Page 1 of 12 Page 1 of 12 TITLE: ANTIBIOTICS IN ADULT PATIENTS EMPIRIC USE GUIDELINES, COLUMBIA UNIVERSITY MEDICAL CENTER MEDICATION GUIDELINE PURPOSE: These are the 2011 guidelines for the empiric use of antibiotics

More information

ANTIBIOTICS IN SEPSIS

ANTIBIOTICS IN SEPSIS ANTIBIOTICS IN SEPSIS Jennifer Curello, PharmD, BCPS Clinical Pharmacist, Infectious Diseases Antimicrobial Stewardship Program Ronald Reagan UCLA Medical Center October 27, 2014 The power of antibiotics

More information

Key words: antibiotics, antiseptics, resistance, burns, comlications, microorganisms.

Key words: antibiotics, antiseptics, resistance, burns, comlications, microorganisms. Nazarchuk Oleksandr, Nahaichuk Vasyl, Paliy Viktor, Kovalenko Iryna. Microbiological aspects of the effectiveness of antimicrobial drugs. Journal of Education, Health and Sport. 2015;5(6):19-28. ISSN 2391-8306.

More information

IDSA GUIDELINES EXECUTIVE SUMMARY

IDSA GUIDELINES EXECUTIVE SUMMARY IDSA GUIDELINES Diagnosis and Management of Complicated Intra-abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America Joseph

More information

How To Get A Drug Plan To Pay For A Prescription From Acpa

How To Get A Drug Plan To Pay For A Prescription From Acpa +B/LVW2I'UXJV5B$SSURYHG 2015 List of Covered s (Formulary) FOR MORE INFORMATION, contact Member Services at 1-855-735-4398 from 8 a.m. to 8 p.m., seven days a week. TTY users call 711. On weekends and

More information

Anti Protozoal. Albendazole Oral Suspension USP Albendazole Tablets USP 400 mg Anti Malarial

Anti Protozoal. Albendazole Oral Suspension USP Albendazole Tablets USP 400 mg Anti Malarial ANTI-INFECTIVES Anti Biotics Levofloxacin Tablets 250, 500, 750 mg Ofloxacin Tablets 200, 400 mg Sparfloxacin Tablets 200 mg Ciprofloxacin Tablets USP 250, 500 mg Ofloxacin & Ornidazole Tablets Nitrofurantoin

More information

Urinary tract infections caused by extended spectrum β-lactamase (ESBL) producing Escherichia coli and Klebsiella pneumoniae

Urinary tract infections caused by extended spectrum β-lactamase (ESBL) producing Escherichia coli and Klebsiella pneumoniae African Journal of Biotechnology Vol. 10(73), pp. 16661-16666, 21 November, 2011 Available online at http://www.academicjournals.org/ajb DOI: 10.5897/AJB11.2449 ISSN 1684 5315 2011 Academic Journals Full

More information

2015 Formulary (List of Covered Drugs)

2015 Formulary (List of Covered Drugs) Blue Cross Medicare Advantage Basic (HMO) SM Blue Cross Medicare Advantage Premier Plus (HMO-POS) SM 015 Formulary (List of Covered Drugs) PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS

More information

Plasmidic Extended-Spectrum -Lactamases in Vibrio cholerae O1 El Tor Isolates in Argentina

Plasmidic Extended-Spectrum -Lactamases in Vibrio cholerae O1 El Tor Isolates in Argentina ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, May 2002, p. 1462 1468 Vol. 46, No. 5 0066-4804/02/$04.00 0 DOI: 10.1128/AAC.46.5.1462 1468.2002 Copyright 2002, American Society for Microbiology. All Rights Reserved.

More information

SURGICAL PROPHYLAXIS: ANTIBIOTIC RECOMMENDATIONS FOR ADULT PATIENTS

SURGICAL PROPHYLAXIS: ANTIBIOTIC RECOMMENDATIONS FOR ADULT PATIENTS Page 1 of 8 TITLE: SURGICAL PROPHYLAXIS: ANTIBIOTIC RECOMMENDATIONS FOR ADULT PATIENTS GUIDELINE: Antibiotics are administered prior to surgical procedures to prevent surgical site infections. PURPOSE:

More information

Clinical Practice Guidelines for Antimicrobial Prophylaxis in Surgery

Clinical Practice Guidelines for Antimicrobial Prophylaxis in Surgery 600 ASHP Therapeutic Guidelines Clinical Practice Guidelines for Antimicrobial Prophylaxis in Surgery These guidelines were developed jointly by the American Society of Health-System Pharmacists (ASHP),

More information

Prescription Drug Guide

Prescription Drug Guide 2012 Prescription Drug Guide Humana Group Medicare Formulary List of covered drugs Humana Group Medicare Plus 3 PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE DRUGS WE COVER IN THIS PLAN. Y0040_PDG12b_Final_522C

More information

Objectives. Fluids. Sterile IV Techniques. How many of you have sterile compounding technique procedures at your institution?

Objectives. Fluids. Sterile IV Techniques. How many of you have sterile compounding technique procedures at your institution? Objectives Intravenous Medications in the Intensive Care Unit Paul Juang, Pharm.D., BCPS Assistant Professor of Pharmacy Practice St. Louis College of Pharmacy April 16, 2011 The speaker has no conflict

More information

Bacterial Infections Caused by Achromobacter xylosoxidans

Bacterial Infections Caused by Achromobacter xylosoxidans Bacterial Infections Caused by Achromobacter xylosoxidans Mohammed Kadum Al-Araji Samah Ali College of Pharmacy, Al-Mustanseriyia University, Baghdad, Iraq. Corresponding author: E-mail: [email protected]

More information

PROJECT LIST GENERIC PRODUCTS

PROJECT LIST GENERIC PRODUCTS PROJECT LIST GENERIC PRODUCTS Acetylcysteine, Effervescent tablets 200 mg, 600 mg Alendronate sodium, Tablets 10, 70 mg Alfuzosin,Tablets 2.5mg Alfuzosin, ER Tablets 10 mg Ambroxol, Effervescent tablets

More information

Antimicrobial Activity and Spectrum of PPI-0903M (T-91825), a Novel Cephalosporin, Tested against a Worldwide Collection of Clinical Strains

Antimicrobial Activity and Spectrum of PPI-0903M (T-91825), a Novel Cephalosporin, Tested against a Worldwide Collection of Clinical Strains ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 2005, p. 3501 3512 Vol. 49, No. 8 0066-4804/05/$08.00 0 doi:10.1128/aac.49.8.3501 3512.2005 Copyright 2005, American Society for Microbiology. All Rights Reserved.

More information

Beta-Lactamase Encoding Gene Among Extended Spectrum B-Lactamase Positive Wound Isolates of Pseudomonas

Beta-Lactamase Encoding Gene Among Extended Spectrum B-Lactamase Positive Wound Isolates of Pseudomonas Arch Pediatr Infect Dis. 2015 October; 3(4): e26362. Published online 2015 October 12. doi: 10.5812/pedinfect.26362 Research Article Molecular Detection of bla VEB-1 Beta-Lactamase Encoding Gene Among

More information

BD Phoenix Automated Microbiology System

BD Phoenix Automated Microbiology System BD Phoenix Automated Microbiology System Resistance Detection Workflow Efficiency Analysis and Communication BD Diagnostics 7 Loveton Circle Sparks, MD 115-0999 800.638.8663 www.bd.com/ds CHROMagar is

More information

Biological Sciences Initiative

Biological Sciences Initiative Biological Sciences Initiative HHMI Student Activities Measuring Antibiotic Resistance Introduction: You might be aware that antibiotics were once thought of as a magic bullet; a nearly perfect drug for

More information

Cluster of urinary tract infections due to XDR Pseudomonas aeruginosa. Dr Marie Hallin Service de Microbiologie Hôpital Erasme

Cluster of urinary tract infections due to XDR Pseudomonas aeruginosa. Dr Marie Hallin Service de Microbiologie Hôpital Erasme Dr Marie Hallin Service de Microbiologie Hôpital Erasme ULB-Hôpital Erasme: 800 beds Nephrology/Renal transplantation 3300 urines/month 15/05/10-2 Urines 13/05/10: BG100504717 (M) 1946 ER WBC: 123/µL RBC:

More information

Intra-abdominal abdominal Infections

Intra-abdominal abdominal Infections Intra-abdominal abdominal Infections Marnie Peterson, Pharm.D., BCPS Dept. of Pediatric Infectious Diseases Medical School University of Minnesota Intra-abdominal abdominal Infections Intra-abdominal abdominal

More information

Beta-lactam antibiotics - Cephalosporins

Beta-lactam antibiotics - Cephalosporins Beta-lactam antibiotics - Cephalosporins Targets - PBP s Activity - Cidal - growing organisms (like the penicillins) Principles of action - Affinity for PBP s Permeability ypropertiesp Stability to bacterial

More information

Outpatient Parenteral Antimicrobial Therapy

Outpatient Parenteral Antimicrobial Therapy Outpatient Parenteral Antimicrobial Therapy Jason E. Bowling, MD a,b, *, James S. Lewis II, PharmD c,d, Aaron D. Owens, MD a,e KEYWORDS Outpatient parenteral antimicrobial therapy Antibiotics Adverse events

More information

SYNDROMIC CASE MANAGEMENT OF RTIs Advantages, Limitations, Optimization

SYNDROMIC CASE MANAGEMENT OF RTIs Advantages, Limitations, Optimization WHO COLLABORATING CENTRE FOR RESEARCH IN HUMAN REPRODUCTION Hôpitaux Universitaires de Genève SYNDROMIC CASE MANAGEMENT OF RTIs Advantages, Limitations, Optimization Dr SALONEY NAZEER Department of Gynaecology

More information

SUMMARY REPORT. Antimicrobials Sold or Distributed for Use in Food-Producing Animals

SUMMARY REPORT. Antimicrobials Sold or Distributed for Use in Food-Producing Animals 2009 SUMMARY REPORT On Antimicrobials Sold or Distributed for Use in Food-Producing Animals Food and Drug Administration Department of Health and Human Services September, 20 This version supersedes the

More information

Antibiotics and Infectious Disease in Otolaryngology-HNS

Antibiotics and Infectious Disease in Otolaryngology-HNS Antibiotics and Infectious Disease in Otolaryngology-HNS Glen T. Porter, MD Faculty Advisor: Francis B. Quinn, MD, FACS The University of Texas Medical Branch at Galveston Department of Otolaryngology

More information

2. Testing in vitro may not always have the desired in vivo effects.

2. Testing in vitro may not always have the desired in vivo effects. ANTIBIOTICS Definition: usually defined as a chemical produced by one microorganism that is capable of killing or inhibiting the growth of other microorganisms. 4 genera capable of producing natural antibiotics:

More information

Treatment of skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus in adults

Treatment of skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus in adults 1 of 6 9/24/2010 11:16 AM Official reprint from UpToDate www.uptodate.com 2010 UpToDate Treatment of skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus in adults Author

More information

GUIDELINES ON UROLOGICAL INFECTIONS

GUIDELINES ON UROLOGICAL INFECTIONS GUIDELINES ON UROLOGICAL INFECTIONS (Text update April 2010) M. Grabe (chairman), T.E. Bjerklund-Johansen, H. Botto, M. Çek, K.G. Naber, R.S. Pickard, P. Tenke, F. Wagenlehner, B. Wullt Introduction Infections

More information

Venkatadri Babu. et al. / International Journal of Biological & Pharmaceutical Research. 2014; 5(1): 66-70.

Venkatadri Babu. et al. / International Journal of Biological & Pharmaceutical Research. 2014; 5(1): 66-70. 66 e- ISSN 0976-3651 Print ISSN 2229-7480 International Journal of Biological & Pharmaceutical Research Journal homepage: www.ijbpr.com IJBPR MULTIDRUG RESISTANT ESCHERICHIA COLI AND KLEBSIELLA PNEUMONIAE

More information

ANTIMICROBIAL USE GUIDELINES

ANTIMICROBIAL USE GUIDELINES ANTIMICROBIAL USE GUIDELINES University of Wisconsin Hospital and Clinics Pharmacy and Therapeutics Committee Department of Pharmacy Drug Policy Program July 2011 to June 2012 Twenty-First Edition PREFACE

More information

May 2015 P&T Updates. Prior Authorization. Traditional. Formulary. Yes No. Formulary. Non Formulary. Non Formulary. Non Formulary

May 2015 P&T Updates. Prior Authorization. Traditional. Formulary. Yes No. Formulary. Non Formulary. Non Formulary. Non Formulary Commercial Triple Tier 4th Tier Applicable Traditional s EVOTAZ 2 2 Alternatives Flovent Diskus/HFA, Pulmicort Flexhaler, Qvar, Asmanex HFA eszopiclone, zaleplon, zolpidem, amitriptyline, mirtazapine,

More information

Environmental reservoirs of antibiotic resistance genes

Environmental reservoirs of antibiotic resistance genes Environmental reservoirs of antibiotic resistance genes Antibiotic resistance in the environment: soil, sediments, water bodies Environment acts as an reservoir for antibiotic resistance genes: -associated

More information

Magellan Rx Medicare Basic (PDP) 2016 Formulary. (List of Covered Drugs)

Magellan Rx Medicare Basic (PDP) 2016 Formulary. (List of Covered Drugs) Magellan Rx Medicare Basic (PDP) 2016 Formulary (List of Covered Drugs) PLEASE READ: THIS DOCUMENT CONTAINS INFORMATION ABOUT THE S WE COVER IN THIS PLAN Formulary File 16144, Version 22 This formulary

More information